Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signaling.

Toxicarioside A is a cardenolide isolated mainly from plants and animals. Emerging evidence demonstrate that cardenolides not only have cardiac effects but also anticancer effects. In this study, we used in vivo models to investigate the antitumor activities of toxicarioside A and the potential mech...

Full description

Bibliographic Details
Main Authors: Feng-Ying Huang, Wen-Li Mei, Yue-Nan Li, Guang-Hong Tan, Hao-Fu Dai, Jun-Li Guo, Hua Wang, Yong-Hao Huang, Huan-Ge Zhao, Song-Lin Zhou, Ying-Ying Lin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3508932?pdf=render
_version_ 1828973043580403712
author Feng-Ying Huang
Wen-Li Mei
Yue-Nan Li
Guang-Hong Tan
Hao-Fu Dai
Jun-Li Guo
Hua Wang
Yong-Hao Huang
Huan-Ge Zhao
Song-Lin Zhou
Ying-Ying Lin
author_facet Feng-Ying Huang
Wen-Li Mei
Yue-Nan Li
Guang-Hong Tan
Hao-Fu Dai
Jun-Li Guo
Hua Wang
Yong-Hao Huang
Huan-Ge Zhao
Song-Lin Zhou
Ying-Ying Lin
author_sort Feng-Ying Huang
collection DOAJ
description Toxicarioside A is a cardenolide isolated mainly from plants and animals. Emerging evidence demonstrate that cardenolides not only have cardiac effects but also anticancer effects. In this study, we used in vivo models to investigate the antitumor activities of toxicarioside A and the potential mechanisms behind them. Murine colorectal carcinoma (CT26) and Lewis lung carcinoma (LL/2) models were established in syngeneic BALB/c and C57BL/6 mice, respectively. We found that the optimum effective dose of toxicarioside A treatment significantly suppressed tumor growth and angiogenesis in CT and LL/2 tumor models in vivo. Northern and Western blot analysis showed significant inhibition of endoglin expression in toxicarioside A-treated human umbilical vein endothelial cells (HUVECs) in vitro and tumor tissues in vivo. Toxicarioside A treatment significantly inhibited cell proliferation, migration and invasion, but did not cause significant cell apoptosis and affected other membrane protein (such as CD31 and MHC I) expression. In addition, TGF-β expression was also significantly inhibited in CT26 and LL/2 tumor cells treated with toxicarioside A. Western blot analysis indicated that Smad1 and phosphorylated Smad1 but not Smad2/3 and phosphorylated Smad2/3 were attenuated in HUVECs treated with toxicarioside A. Smad1 and Smad2/3 signaling remained unchanged in CT26 and LL/2 tumor cells treated with toxicarioside A. Endoglin knockout by small interfering RNA against endoglin induced alternations in Smad1 and Smad2/3 signaling in HUVECs. Our results indicate that toxicarioside A suppresses tumor growth through inhibition of endoglin-related tumor angiogenesis, which involves in the endoglin/TGF-β signal pathway.
first_indexed 2024-12-14T13:39:27Z
format Article
id doaj.art-b926181cd6434a9ea0919349abadd3db
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T13:39:27Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b926181cd6434a9ea0919349abadd3db2022-12-21T22:59:29ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01711e5035110.1371/journal.pone.0050351Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signaling.Feng-Ying HuangWen-Li MeiYue-Nan LiGuang-Hong TanHao-Fu DaiJun-Li GuoHua WangYong-Hao HuangHuan-Ge ZhaoSong-Lin ZhouYing-Ying LinToxicarioside A is a cardenolide isolated mainly from plants and animals. Emerging evidence demonstrate that cardenolides not only have cardiac effects but also anticancer effects. In this study, we used in vivo models to investigate the antitumor activities of toxicarioside A and the potential mechanisms behind them. Murine colorectal carcinoma (CT26) and Lewis lung carcinoma (LL/2) models were established in syngeneic BALB/c and C57BL/6 mice, respectively. We found that the optimum effective dose of toxicarioside A treatment significantly suppressed tumor growth and angiogenesis in CT and LL/2 tumor models in vivo. Northern and Western blot analysis showed significant inhibition of endoglin expression in toxicarioside A-treated human umbilical vein endothelial cells (HUVECs) in vitro and tumor tissues in vivo. Toxicarioside A treatment significantly inhibited cell proliferation, migration and invasion, but did not cause significant cell apoptosis and affected other membrane protein (such as CD31 and MHC I) expression. In addition, TGF-β expression was also significantly inhibited in CT26 and LL/2 tumor cells treated with toxicarioside A. Western blot analysis indicated that Smad1 and phosphorylated Smad1 but not Smad2/3 and phosphorylated Smad2/3 were attenuated in HUVECs treated with toxicarioside A. Smad1 and Smad2/3 signaling remained unchanged in CT26 and LL/2 tumor cells treated with toxicarioside A. Endoglin knockout by small interfering RNA against endoglin induced alternations in Smad1 and Smad2/3 signaling in HUVECs. Our results indicate that toxicarioside A suppresses tumor growth through inhibition of endoglin-related tumor angiogenesis, which involves in the endoglin/TGF-β signal pathway.http://europepmc.org/articles/PMC3508932?pdf=render
spellingShingle Feng-Ying Huang
Wen-Li Mei
Yue-Nan Li
Guang-Hong Tan
Hao-Fu Dai
Jun-Li Guo
Hua Wang
Yong-Hao Huang
Huan-Ge Zhao
Song-Lin Zhou
Ying-Ying Lin
Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signaling.
PLoS ONE
title Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signaling.
title_full Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signaling.
title_fullStr Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signaling.
title_full_unstemmed Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signaling.
title_short Toxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signaling.
title_sort toxicarioside a inhibits tumor growth and angiogenesis involvement of tgf β endoglin signaling
url http://europepmc.org/articles/PMC3508932?pdf=render
work_keys_str_mv AT fengyinghuang toxicariosideainhibitstumorgrowthandangiogenesisinvolvementoftgfbendoglinsignaling
AT wenlimei toxicariosideainhibitstumorgrowthandangiogenesisinvolvementoftgfbendoglinsignaling
AT yuenanli toxicariosideainhibitstumorgrowthandangiogenesisinvolvementoftgfbendoglinsignaling
AT guanghongtan toxicariosideainhibitstumorgrowthandangiogenesisinvolvementoftgfbendoglinsignaling
AT haofudai toxicariosideainhibitstumorgrowthandangiogenesisinvolvementoftgfbendoglinsignaling
AT junliguo toxicariosideainhibitstumorgrowthandangiogenesisinvolvementoftgfbendoglinsignaling
AT huawang toxicariosideainhibitstumorgrowthandangiogenesisinvolvementoftgfbendoglinsignaling
AT yonghaohuang toxicariosideainhibitstumorgrowthandangiogenesisinvolvementoftgfbendoglinsignaling
AT huangezhao toxicariosideainhibitstumorgrowthandangiogenesisinvolvementoftgfbendoglinsignaling
AT songlinzhou toxicariosideainhibitstumorgrowthandangiogenesisinvolvementoftgfbendoglinsignaling
AT yingyinglin toxicariosideainhibitstumorgrowthandangiogenesisinvolvementoftgfbendoglinsignaling